Berezin Alexander E相关文献与解析，生知库

The Association of Adropin with Asymptomatic Coronary Calcification in Patients in Early Stages of Chronic Kidney Disease

Adropin与慢性肾脏病早期患者无症状冠状动脉钙化的相关性

期刊:International Journal of Molecular Sciences

影响因子:4.9

doi:10.3390/ijms26167816

Berezina, Tetiana A; Berezin, Oleksandr O; Novikov, Evgen V; Berezin, Alexander E

发表日期：2025

文献求助收藏

Low Levels of Adropin Predicted New Incidents of Atrial Fibrillation in Patients with Heart Failure with Preserved Ejection Fraction

低水平的Adropin可预测射血分数保留型心力衰竭患者发生新的房颤

期刊:Biomolecules

影响因子:4.8

doi:10.3390/biom15081171

Berezina, Tetiana A; Berezin, Oleksandr O; Novikov, Evgen V; Berezin, Alexander E

Early predictors of carotid atherosclerosis in patients with type 2 diabetes mellitus

2型糖尿病患者颈动脉粥样硬化的早期预测因素

期刊:World Journal of Diabetes

影响因子:4.6

doi:10.4239/wjd.v16.i10.112631

Serum Levels of Irisin Are Positively Associated with Improved Cardiac Function in Patients with Heart Failure with Reduced Ejection Fraction

血清鸢尾素水平与射血分数降低的心力衰竭患者的心脏功能改善呈正相关

期刊:Biomedicines

影响因子:3.9

doi:10.3390/biomedicines13040866

Berezin, Alexander E; Berezina, Tetiana A; Novikov, Evgen V; Berezin, Oleksandr O

Protective activity of adipose-derived stem cell extracellular vesicles in ischemia and/or reperfusion

脂肪干细胞来源的细胞外囊泡在缺血和/或再灌注损伤中的保护作用

期刊:World Journal of Stem Cells

影响因子:3.6

doi:10.4252/wjsc.v17.i1.102280

Predictive value of the systemic immune inflammation index in recurrence of atrial fibrillation after radiofrequency catheter ablation

系统性免疫炎症指数对射频消融术后房颤复发的预测价值

期刊:World Journal of Cardiology

影响因子:2.8

doi:10.4330/wjc.v17.i1.102981

On MANTA vascular closure devices following veno arterial extracorporeal membrane oxygenation: Effectiveness and complications

MANTA血管闭合装置在静脉-动脉体外膜肺氧合术后的应用：有效性和并发症

期刊:World Journal of Cardiology

影响因子:2.8

doi:10.4330/wjc.v17.i3.101768

Low levels of adropin are associated with acute kidney injury after decongestion in patients with acutely decompensated heart failure

急性失代偿性心力衰竭患者在充血缓解后，低水平的adropin与急性肾损伤相关。

期刊:Journal of Molecular and Cellular Cardiology Plus

影响因子:2.2

doi:10.1016/j.jmccpl.2025.100302

Berezin, Alexander E; Berezina, Tetiana A; Novikov, Evgen V; Berezin, Oleksandr O

Implementation of risk-based lipid-lowering therapies in older (age ≥ 65 years) and very-old adults (age ≥ 75 years) with ischemic heart disease in the greater Salzburg region

在萨尔茨堡大区，对患有缺血性心脏病的老年人（≥65岁）和高龄老人（≥75岁）实施基于风险的降脂治疗。

期刊:Frontiers in Pharmacology

影响因子:4.8

doi:10.3389/fphar.2024.1357334

Kopp, Kristen; Motloch, Lukas J; Wernly, Bernhard; Berezin, Alexander E; Maringgele, Victoria; Dieplinger, Anna; Hoppe, Uta C; Lichtenauer, Michael

Retraction: The utility of biomarker risk prediction score in patients with chronic heart failure

撤稿：生物标志物风险预测评分在慢性心力衰竭患者中的应用

The Association of Adropin with Asymptomatic Coronary Calcification in Patients in Early Stages of Chronic Kidney Disease

Adropin与慢性肾脏病早期患者无症状冠状动脉钙化的相关性

Low Levels of Adropin Predicted New Incidents of Atrial Fibrillation in Patients with Heart Failure with Preserved Ejection Fraction

低水平的Adropin可预测射血分数保留型心力衰竭患者发生新的房颤

Early predictors of carotid atherosclerosis in patients with type 2 diabetes mellitus

2型糖尿病患者颈动脉粥样硬化的早期预测因素

Serum Levels of Irisin Are Positively Associated with Improved Cardiac Function in Patients with Heart Failure with Reduced Ejection Fraction

血清鸢尾素水平与射血分数降低的心力衰竭患者的心脏功能改善呈正相关

Protective activity of adipose-derived stem cell extracellular vesicles in ischemia and/or reperfusion

脂肪干细胞来源的细胞外囊泡在缺血和/或再灌注损伤中的保护作用

Predictive value of the systemic immune inflammation index in recurrence of atrial fibrillation after radiofrequency catheter ablation

系统性免疫炎症指数对射频消融术后房颤复发的预测价值

On MANTA vascular closure devices following veno arterial extracorporeal membrane oxygenation: Effectiveness and complications

MANTA血管闭合装置在静脉-动脉体外膜肺氧合术后的应用：有效性和并发症

Low levels of adropin are associated with acute kidney injury after decongestion in patients with acutely decompensated heart failure

急性失代偿性心力衰竭患者在充血缓解后，低水平的adropin与急性肾损伤相关。

Implementation of risk-based lipid-lowering therapies in older (age ≥ 65 years) and very-old adults (age ≥ 75 years) with ischemic heart disease in the greater Salzburg region

在萨尔茨堡大区，对患有缺血性心脏病的老年人（≥65岁）和高龄老人（≥75岁）实施基于风险的降脂治疗。